Hemotune
Lukas Langenegger began their career in 2008 as a Trainee at UBS. In 2013, they joined ETH Zurich as a PhD Student, Research Assistant, and Teaching Assistant. In 2017, they became the CEO & co-founder of hemotune.
Lukas Langenegger completed a Bachelor of Science (BSc) in Chemical Engineering from ETH Zürich between 2010 and 2013. In 2013, they also began a Master of Science (MSc) in Chemical and Bioengineering from ETH Zürich, which they completed in 2015. During this time, they also completed a Master's thesis in Chemical Engineering from the Massachusetts Institute of Technology in 2014.
This person is not in any teams
Hemotune
Hemotune is a medical device company that develops a therapeutic blood purification platform for treatment of health ailments.